HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morrow, C. S. Articles by Townsend, A. J. Search for Related Content PubMed PubMed Citation Articles by Morrow, C. S. Articles by Townsend, A. J. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 32, 20114-20120, August 7, 1998

Coordinated Action of Glutathione S-Transferases (GSTs) and Multidrug Resistance Protein 1 (MRP1) in Antineoplastic Drug Detoxification
MECHANISM OF GST A1-1- AND MRP1-ASSOCIATED RESISTANCE TO CHLORAMBUCIL IN MCF7 BREAST CARCINOMA CELLS

From the Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157 and ^§ Wadsworth Center, Albany, New York 12201

To examine the role of multidrug resistance protein 1 (MRP1) and glutathione S-transferases (GSTs) in cellular resistance to antineoplastic drugs, derivatives of MCF7 breast carcinoma cells were developed that express MRP1 in combination with one of three human cytosolic isozymes of GST. Expression of MRP1 alone confers resistance to several drugs representing the multidrug resistance phenotype, drugs including doxorubicin, vincristine, etoposide, and mitoxantrone. However, co-expression with MRP1 of any of the human GST isozymes A1-1, M1-1, or P1-1 failed to augment MRP1-associated resistance to these drugs. In contrast, combined expression of MRP1 and GST A1-1 conferred ~4-fold resistance to the anticancer drug chlorambucil. Expression of MRP1 alone failed to confer resistance to chlorambucil, showing that the observed protection from chlorambucil cytotoxicity was absolutely dependent upon GST A1-1 protein. Moreover, using inhibitors of GST (dicumarol) or MRP1 (sulfinpyrazone), it was shown that in MCF7 cells resistance to chlorambucil requires both intact MRP1-dependent efflux pump activity and, for full protection, GST A1-1 catalytic activity. These results are the first demonstration that GST A1-1 and MRP1 can act in synergy to protect cells from the cytotoxicity of a nitrogen mustard, chlorambucil.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				C. Peklak-Scott, P. K. Smitherman, A. J. Townsend, and C. S. Morrow Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin Mol. Cancer Ther., October 1, 2008; 7(10): 3247 - 3255. [Abstract] [Full Text] [PDF]

				M. B. Sibhatu, P. K. Smitherman, A. J. Townsend, and C. S. Morrow Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane Carcinogenesis, April 1, 2008; 29(4): 807 - 815. [Abstract] [Full Text] [PDF]

				M. E. Kushman, S. L. Kabler, S. Ahmad, J. Doehmer, C. S. Morrow, and A. J. Townsend Protective Efficacy of hGSTM1-1 against B[a]P and (+)- or ( )-B[a]P-7,8-Dihydrodiol Cytotoxicity, Mutagenicity, and Macromolecular Adducts in V79 Cells Coexpressing hCYP1A1 Toxicol. Sci., September 1, 2007; 99(1): 51 - 57. [Abstract] [Full Text] [PDF]

				Y. Yoshimoto, C. K. Augustine, J. S. Yoo, P. A. Zipfel, M. A. Selim, S. K. Pruitt, H. S. Friedman, F. Ali-Osman, and D. S. Tyler Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents Mol. Cancer Ther., May 1, 2007; 6(5): 1492 - 1500. [Abstract] [Full Text] [PDF]

				D. S. Riddick, C. Lee, S. Ramji, E. C. Chinje, R. L. Cowen, K. J. Williams, A. V. Patterson, I. J. Stratford, C. S. Morrow, A. J. Townsend, et al. CANCER CHEMOTHERAPY AND DRUG METABOLISM Drug Metab. Dispos., August 1, 2005; 33(8): 1083 - 1096. [Abstract] [Full Text] [PDF]

				L. A. Ralat and R. F. Colman Glutathione S-Transferase Pi Has at Least Three Distinguishable Xenobiotic Substrate Sites Close to Its Glutathione-binding Site J. Biol. Chem., November 26, 2004; 279(48): 50204 - 50213. [Abstract] [Full Text] [PDF]

				J. Mauzeroll and A. J. Bard Scanning electrochemical microscopy of menadione-glutathione conjugate export from yeast cells PNAS, May 25, 2004; 101(21): 7862 - 7867. [Abstract] [Full Text] [PDF]

				P. Depeille, P. Cuq, S. Mary, I. Passagne, A. Evrard, D. Cupissol, and L. Vian Glutathione S-Transferase M1 and Multidrug Resistance Protein 1 Act in Synergy to Protect Melanoma Cells from Vincristine Effects Mol. Pharmacol., April 1, 2004; 65(4): 897 - 905. [Abstract] [Full Text]

				P. K. Smitherman, A. J. Townsend, T. E. Kute, and C. S. Morrow Role of Multidrug Resistance Protein 2 (MRP2, ABCC2) in Alkylating Agent Detoxification: MRP2 Potentiates Glutathione S-Transferase A1-1-Mediated Resistance to Chlorambucil Cytotoxicity J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 260 - 267. [Abstract] [Full Text] [PDF]

				L. A. Ralat and R. F. Colman Monobromobimane occupies a distinct xenobiotic substrate site in glutathione S-transferase {pi} Protein Sci., November 1, 2003; 12(11): 2575 - 2587. [Abstract] [Full Text] [PDF]

				A. C. Lockhart, R. G. Tirona, and R. B. Kim Pharmacogenetics of ATP-binding Cassette Transporters in Cancer and Chemotherapy Mol. Cancer Ther., July 1, 2003; 2(7): 685 - 698. [Abstract] [Full Text] [PDF]

				A. Rajagopal, A. C. Pant, S. M. Simon, and Y. Chen In Vivo Analysis of Human Multidrug Resistance Protein 1 (MRP1) Activity Using Transient Expression of Fluorescently Tagged MRP1 Cancer Res., January 1, 2002; 62(2): 391 - 396. [Abstract] [Full Text] [PDF]

				R. L. Divi, Y. P. Dragan, H. C. Pitot, and M. C. Poirier Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen Carcinogenesis, October 1, 2001; 22(10): 1693 - 1699. [Abstract] [Full Text] [PDF]

				S. K. Diah, P. K. Smitherman, J. Aldridge, E. L. Volk, E. Schneider, A. J. Townsend, and C. S. Morrow Resistance to Mitoxantrone in Multidrug-resistant MCF7 Breast Cancer Cells: Evaluation of Mitoxantrone Transport and the Role of Multidrug Resistance Protein Family Proteins Cancer Res., July 1, 2001; 61(14): 5461 - 5467. [Abstract] [Full Text] [PDF]

				M. O'Brien, G. D. Kruh, and K. D. Tew The Influence of Coordinate Overexpression of Glutathione Phase II Detoxification Gene Products on Drug Resistance J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 480 - 487. [Abstract] [Full Text]

				J. Wang, S. Bauman, and R. F. Colman Probing Subunit Interactions in Alpha Class Rat Liver Glutathione S-Transferase with the Photoaffinity Label Glutathionyl S-[4-(Succinimidyl)benzophenone] J. Biol. Chem., February 25, 2000; 275(8): 5493 - 5503. [Abstract] [Full Text] [PDF]

				M. Stanulla, M. Schrappe, A. M. Brechlin, M. Zimmermann, and K. Welte Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study Blood, February 15, 2000; 95(4): 1222 - 1228. [Abstract] [Full Text] [PDF]

				W. R. Fields, C. S. Morrow, J. Doehmer, and A. J. Townsend Expression of stably transfected murine glutathione S-transferase A3-3 protects against nucleic acid alkylation and cytotoxicity by aflatoxin B1 in hamster V79 cells expressing rat cytochrome P450-2B1 Carcinogenesis, June 1, 1999; 20(6): 1121 - 1125. [Abstract] [Full Text] [PDF]

				C. M. Paumi, B. G. Ledford, P. K. Smitherman, A. J. Townsend, and C. S. Morrow Role of Multidrug Resistance Protein 1 (MRP1) and Glutathione S-Transferase A1-1 in Alkylating Agent Resistance. KINETICS OF GLUTATHIONE CONJUGATE FORMATION AND EFFLUX GOVERN DIFFERENTIAL CELLULAR SENSITIVITY TO CHLORAMBUCIL VERSUS MELPHALAN TOXICITY J. Biol. Chem., March 9, 2001; 276(11): 7952 - 7956. [Abstract] [Full Text] [PDF]